Free Review Articles on AMD macular degeneration                                 Metatextbook

Freie Reviews über AMD Altersabhaengige Makuladegeneration                                 Look here for Journal Homepages

  • AMD macular degeneration
  • Pegaptanib
  • Ranibizumab
  • Drusen
  • Phototoxicity
  • Stroke (BASKET)
  • Apolipoprotein B
  • Retina (BASKET)
  • Eye and orbita (Neovascularization)
    • Nr.Year

    OPEN

    		Titleusers

    say

    		rate

    good

    		rate

    bad

    no link

    		Citation
    12003Age related macular degeneration.



    		+-nlBMJ 326(7387):485-8 (2003) Chopdar A
    22007An update of treatment options for neovascular age-related macular degeneration.



    		+-nlHong Kong Med J 13(6):460-70 (2007) Iu LP
    32005Age-related macular degeneration.



    		+-nlUlster Med J 74(2):82-92 (2005) McConnell V
    42003Age-related macular degeneration: evaluation and treatment.



    		+-nlCleve Clin J Med 70(12):1017-8, 1020, 1023-5 passim (2003) Moshfeghi DM
    52006Ranibizumab in neovascular age-related macular degeneration.



    		+-nlClin Interv Aging 1(4):451-66 (2006) Kenneth TE
    62009The treatment of wet age-related macular degeneration.



    		+-nlDtsch Arztebl Int 106(18):312-7 (2009) Joussen AM
    72007Age-related macular degeneration: a target for nanotechnology derived medicines.



    		+-nlInt J Nanomedicine 2(1):65-77 (2007) Birch DG
    82006Pegaptanib in the treatment of wet, age-related macular degeneration.



    		+-nlInt J Nanomedicine 1(3):263-8 (2006) Vinores SA
    92008A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration.



    		+-nlHealth Technol Assess 12(27):iii-iv, ix-124 (2008) Karnon J
    102008Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation.



    		+-nlHealth Technol Assess 12(16):iii-iv, ix-201 (2008) Colquitt JL
    112003Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation.



    		+-nlHealth Technol Assess 7(9):v-vi, 1-98 (2003) Meads C
    122007Molecular genetics of AMD and current animal models.



    		+-nlAngiogenesis 10(2):119-32 (2007) Edwards AO
    132009The molecular genetic basis of age-related macular degeneration: an overview.



    		+-nlJ Genet 88(4):425-49 (2009) Katta S
    141998Age-related macular degeneration.



    		+-nlPostgrad Med J 74(870):203-7 (1998)
    152000External beam radiotherapy in exudative age-related macular degeneration: a pooled analysis of phase I data.



    		+-nlBr J Radiol 73(867):305-13 (2000)
    162010Newly diagnosed exudative age-related macular degeneration treated with pegaptanib sodium monotherapy in US community-based practices: medical chart review study.



    		+-nlBMC Ophthalmol 10():2 (2010) Weber PA
    172007Use of intravitreal injection of triamcinolone acetonide in the treatment of age-related macular degeneration.



    		+-nlIndian J Ophthalmol 55(6):431-5 (2007) Gopal L
    182007Introduction, mechanism of action and rationale for anti-vascular endothelial growth factor drugs in age-related macular degeneration.



    		+-nlIndian J Ophthalmol 55(6):413-5 (2007) Kim R
    192000New approaches in the management of choroidal neovascular membrane in age-related macular degeneration.



    		+-nlIndian J Ophthalmol 48(4):263-78 (2000)
    202007An update on the genetics of age-related macular degeneration.



    		+-nlMol Vis 13():196-205 (2007) Scholl HP
    211999Pathogenesis and Treatment of Age-Related Macular Degeneration: Current Knowledge and Leads for Future Research. June 4-6, 1998. Baltimore, Maryland, USA. Proceedings.



    		+-nlMol Vis 5(-):24-35 (1999)
    221999Changes in choriocapillaris and retinal pigment epithelium in age-related macular degeneration.



    		+-nlMol Vis 5(-):35 (1999)
    231999The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration.



    		+-nlMol Vis 5(-):34 (1999)
    241983Make your partnership work by adhering to a well-defined agreement.



    		+-nlCan Doct 49(9):79-80 (1983)
    251983Are you prepared to invest in a medical office building?



    		+-nlCan Doct 49(9):67-9 (1983)
    261999Cell death in age-related macular degeneration.



    		+-nlMol Vis 5(-):31 (1999)
    271999What can we learn about age-related macular degeneration from other retinal diseases?



    		+-nlMol Vis 5(-):30 (1999)
    281999The genetics of age-related macular degeneration.



    		+-nlMol Vis 5(-):29 (1999)
    291999Molecular composition of drusen as related to substructural phenotype.



    		+-nlMol Vis 5(-):28 (1999)
    301999Histopathology of age-related macular degeneration.



    		+-nlMol Vis 5(-):27 (1999)
    311999Epidemiology of age-related macular degeneration.



    		+-nlMol Vis 5(-):26 (1999)
    321999The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration.



    		+-nlMol Vis 5(-):25 (1999)
    332009Treatment of neovascular age-related macular degeneration: Current therapies.



    		+-nlClin Ophthalmol 3():175-82 (2009) Augustin AJ
    342009Age-related macular degeneration: experimental and emerging treatments.



    		+-nlClin Ophthalmol 3():167-74 (2009) Hubschman JP
    352009Age-related macular degeneration: current treatments.



    		+-nlClin Ophthalmol 3():155-66 (2009) Hubschman JP
    362008Inhibitors of vascular endothelial growth factor (VEGF) in the management of neovascular age-related macular degeneration: a review of current practice.



    		+-nlClin Exp Optom 91(5):427-37 (2008) van Wijngaarden P
    372007Age-related maculopathy in the light of ischaemia.



    		+-nlClin Exp Optom 90(4):263-71 (2007) Feigl B
    382005Treatment of age-related macular degeneration.



    		+-nlClin Exp Optom 88(5):322-34 (2005) Bylsma GW
    392005Objective functional assessment of age-related maculopathy: a special application for the multifocal electroretinogram.



    		+-nlClin Exp Optom 88(5):304-12 (2005) Feigl B
    402005Assessment of age-related maculopathy using subjective vision tests.



    		+-nlClin Exp Optom 88(5):292-303 (2005) Lovie-Kitchin J
    412001The genetics of age-related macular degeneration.



    		+-nlClin Exp Optom 84(4):182-189 (2001) Guymer R
    422006Lesion morphology in age-related macular degeneration and its therapeutic significance.



    		+-nlArch Ophthalmol 124(6):807-12 (2006) Beaumont PE
    432004Scanning laser entoptic perimetry for the detection of age-related macular degeneration.



    		+-nlArch Ophthalmol 122(11):1647-51 (2004) Freeman WR
    442007Guidance for the treatment of neovascular age-related macular degeneration.



    		+-nlActa Ophthalmol Scand 85(5):486-94 (2007) Schmidt-Erfurth UM
    452007New therapies for neovascular age-related macular degeneration: critical appraisal of the current evidence.



    		+-nlActa Ophthalmol Scand 85(1):6-20 (2007) Virgili G
    462006Age-related maculopathy and the impact of blue light hazard.



    		+-nlActa Ophthalmol Scand 84(1):4-15 (2006) Algvere PV
    472003Drusen maculopathy: a risk factor for AMD. Can we prevent visual loss?



    		+-nlActa Ophthalmol Scand 81(5):427-9 (2003) Algvere PV
    482003Recent advances in the treatment of exudative age-related macular degeneration, including transpupillary thermotherapy.



    		+-nlActa Ophthalmol Scand 81(2):103-4 (2003) Ciulla TA
    492002Age-related maculopathy: pathogenetic features and new treatment modalities.



    		+-nlActa Ophthalmol Scand 80(2):136-43 (2002)
    502001Ocular perfusion and age-related macular degeneration.



    		+-nlActa Ophthalmol Scand 79(2):108-15 (2001)
    512010Identifying systemic safety signals following intravitreal bevacizumab: systematic review of the literature and the Canadian Adverse Drug Reaction Database.



    		+-nlCan J Ophthalmol 45(3):231-8 (2010) Micieli JA
    522010Pharmacologic management of neovascular age-related macular degeneration: systematic review of economic evidence and primary economic evaluation.



    		+-nlCan J Ophthalmol 45(3):223-30 (2010) Hodge W
    532010Triple therapy for neovascular age-related macular degeneration (verteporfin photodynamic therapy, intravitreal dexamethasone, and intravitreal bevacizumab).



    		+-nlCan J Ophthalmol 45(1):36-40 (2010) Ehmann D
    542008Age-related macular degeneration and low-vision rehabilitation: a systematic review.



    		+-nlCan J Ophthalmol 43(2):180-7 (2008) Hooper P
    552005Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration.



    		+-nlCan J Ophthalmol 40(3):352-68 (2005) Ng EW
    562005Surgical management of age-related macular degeneration.



    		+-nlCan J Ophthalmol 40(3):341-51 (2005) Conti SM
    572005Rheopheresis for age-related macular degeneration: clinical results and putative mechanism of action.



    		+-nlCan J Ophthalmol 40(3):332-40 (2005) Pulido JS
    582005Laser prophylaxis for age-related macular degeneration.



    		+-nlCan J Ophthalmol 40(3):320-31 (2005) Hsu J
    592005Preferred retinal loci and macular scotoma characteristics in patients with age-related macular degeneration.



    		+-nlCan J Ophthalmol 40(3):303-12 (2005) Schuchard RA
    602005Genetic aspects of age-related macular degeneration.



    		+-nlCan J Ophthalmol 40(3):288-92 (2005) MacDonald IM
    612005Age-related macular degeneration: economic burden and value-based medicine analysis.



    		+-nlCan J Ophthalmol 40(3):277-87 (2005) Brown MM
    622005Current concepts in macular degeneration: introduction.



    		+-nlCan J Ophthalmol 40(3):254-5 (2005) Sharma S
    632008[Update on the genetics of age-related macular degeneration].



    		+-nlJ Fr Ophtalmol 31(6 Pt 1):630-7 (2008) Fajnkuchen F
    642007[Toward prevention of age-related macular degeneration].



    		+-nlJ Fr Ophtalmol 30(5):449-55 (2007) Souied E
    652003[Indocyanine green angiography in age-related macular degeneration].



    		+-nlJ Fr Ophtalmol 26(8):854-63 (2003) Conrath J
    662007Towards a rational approach to combination therapy for neovascular age-related macular degeneration.



    		+-nlBr J Ophthalmol 91(2):130-1 (2007) Arroyo JG
    672006Evolving European guidance on the medical management of neovascular age related macular degeneration.



    		+-nlBr J Ophthalmol 90(9):1188-96 (2006) Chakravarthy U
    682006Which treatment is best for which AMD patient?



    		+-nlBr J Ophthalmol 90(2):128-30 (2006) Kroll P
    692001The role of choroidal haemodynamic abnormalities in the pathogenesis of age related macular degeneration.



    		+-nlBr J Ophthalmol 85(12):1399-400 (2001)
    702001Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy.



    		+-nlBr J Ophthalmol 85(4):483-95 (2001)
    712000Foveal translocation for exudative age related macular degeneration.



    		+-nlBr J Ophthalmol 84(4):344-5 (2000)
    722000Clinicopathological correlation in exudative age related macular degeneration: histological differentiation between classic and occult choroidal neovascularisation.



    		+-nlBr J Ophthalmol 84(3):239-43 (2000)
    731999Photocoagulation of subfoveal choroidal neovascular membranes in age related macular degeneration: the impact of the macular photocoagulation study in the United Kingdom and Republic of Ireland.



    		+-nlBr J Ophthalmol 83(10):1103-4 (1999)
    741999Long term results of radiotherapy for subfoveal choroidal neovascularisation in age related macular degeneration.



    		+-nlBr J Ophthalmol 83(8):923-8 (1999)
    751999Macular pigment and age related macular degeneration.



    		+-nlBr J Ophthalmol 83(7):867-77 (1999)
    761998Alternative therapies in exudative age related macular degeneration.



    		+-nlBr J Ophthalmol 82(12):1441-3 (1998)
    771996Laser treatment of soft drusen in age-related maculopathy.



    		+-nlBr J Ophthalmol 80(1):4 (1996) Sarks S
    781993Choroidal neovascularisation in age-related macular disease.



    		+-nlBr J Ophthalmol 77(10):614-5 (1993)
    792003The genetics of inherited macular dystrophies.



    		+-nlJ Med Genet 40(9):641-50 (2003)
    802005[Hereditary macular dystrophies].



    		+-nlJ Fr Ophtalmol 28(1):113-24 (2005)
    812003[Macular dystrophies].



    		+-nlJ Fr Ophtalmol 26(7):743-62 (2003)
    821996Molecular genetics of macular dystrophies.



    		+-nlBr J Ophthalmol 80(11):1018-22 (1996)
    832007Treatment of exudative age-related macular degeneration: many factors to consider.



    		+-nlAm J Ophthalmol 144(2):281-3 (2007)
    842007New treatments for neovascular acute macular degeneration.



    		+-nlBMJ 334(7588):269-70 (2007)
    852010Age-related macular degeneration: why should stroke physicians care?



    		+-nlStroke 41(4):575-6 (2010)
    862010Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration.



    		+-nlJ Lipid Res 51(3):451-67 (2010)
    872010Therapeutic targets in age-related macular disease.



    		+-nlJ Clin Invest 120(9):3033-41 (2010)
    882007Age-related macular degeneration and recent developments: new hope for old eyes?



    		+-nlPostgrad Med J 83(979):301-7 (2007)
    892010Age-related macular degeneration.



    		+-nlCMAJ 182(16):1759 (2010)
    902006Age-related macular degeneration (AMD): pathogenesis and therapy.



    		+-nlPharmacol Rep 58(3):353-63 (2006)
    912006The role of optical coherence tomography (OCT) in the diagnosis and management of retinal angiomatous proliferation (RAP) in patients with age-related macular degeneration.



    		+-nlAnn Acad Med Singapore 35(6):420-4 (2006)
    922010Age-related macular degeneration: genetic and environmental factors of disease.



    		+-nlMol Interv 10(5):271-81 (2010)
    932010Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications.



    		+-nlMediators Inflamm 2010(-):- (2010)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.